ILMN

Illumina, Inc.

Technology
186.65 down -3.60 -1.89% Pre-Market
2026-07-17 • USD

Key Metrics

Market Cap 28.24B
EV 27.64B
Shares Out 151.30M
Revenue (ttm)
Net Income 952.00M
Beta
P/E
Forward P/E
EPS (ttm) $6.18
P/S
P/B 10.67
P/FCF
P/C
EV/Sales
EV/EBITDA
ROA 14.51%
ROE 38.59%
ROIC
Gross Margin
Oper. Margin
Profit Margin
Debt/Eq 0.21
LT Debt/Cap
Quick Ratio 1.21
Current Ratio 1.75
Book/sh 17.49
Cash/sh 7.12
Div Yield
Div TTM
Payout Ratio
SMA20 2.27%
SMA50 13.12%
SMA200 38.41%
Volume 1,214,011
Avg Volume 1.73M
Rel Volume 0.7
Perf Week -1.79%
Perf Month 15.27%
Perf Quarter 40.49%
Perf Half Y 26.83%
Perf YTD 42.31%
Perf Year 94.14%
Perf 3Y 4.29%
Perf 5Y -60.58%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Illumina, Inc. is a global leader in sequencing- and array-based solutions for genetic and genomic analysis. The company develops and markets integrated sequencing and microarray

Name
Illumina, Inc.
Industry
Technology
CEO
Jacob Thaysen · Chief Executive Officer
Employees
7,500 as of 2025-12-28
IPO Date
2018-11-05
Phone
(858) 202-4500
Address
5200 Illumina Way, San Diego, CA 92122
Website
www.illumina.com

Key Executives

Name Title FY Pay
Patricia Leckman Chief People Officer
Ankur Dhingra Chief Financial Officer
Scott Davies Chief Legal Officer
Steven Barnard Chief Technology Officer
Jacob Thaysen Chief Executive Officer

Latest News